|
MLL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.285000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.492200E-01 |
| Normal-vs-Stage2 |
5.195800E-01 |
| Normal-vs-Stage3 |
5.522000E-01 |
| Normal-vs-Stage4 |
7.260000E-01 |
| Stage1-vs-Stage2 |
8.670800E-01 |
| Stage1-vs-Stage3 |
9.864600E-01 |
| Stage1-vs-Stage4 |
9.399200E-01 |
| Stage2-vs-Stage3 |
8.692200E-01 |
| Stage2-vs-Stage4 |
8.348600E-01 |
| Stage3-vs-Stage4 |
9.183200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.231600E-01 |
| Normal-vs-AfricanAmerican |
5.536200E-01 |
| Normal-vs-Asian |
9.360000E-01 |
| Caucasian-vs-AfricanAmerican |
9.130400E-01 |
| Caucasian-vs-Asian |
8.972000E-01 |
| AfricanAmerican-vs-Asian |
8.578200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.057600E-01 |
| Normal-vs-Female |
4.433800E-01 |
| Male-vs-Female |
1.200760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.369800E-01 |
| Normal-vs-Extreme_Weight |
3.005400E-01 |
| Normal-vs-Obese |
7.533600E-01 |
| Normal-vs-Extreme_Obese |
2.756400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.069000E-01 |
| Normal_Weight-vs-Obese |
1.720360E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.397200E-01 |
| Extreme_Weight-vs-Obese |
2.362600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.557600E-01 |
| Obese-vs-Extreme_Obese |
2.276400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.013200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.967020E-01 |
| Normal-vs-Age(61-80Yrs) |
2.995800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.829000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.775800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.126630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.204800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.600400E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.419200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.326200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.310000E-01 |
| Normal-VS-Type2 PRCC |
2.841700E-03 |
| Normal-VS-KIRP CIMP |
6.113000E-01 |
| Normal-VS-Unclassified PRCC |
2.425800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.319550E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.626400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.674200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.381500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.463400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.638000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.568390E-02 |
| Normal-vs-N1 |
6.965600E-01 |
| Normal-vs-N2 |
3.187000E-01 |
| N0-vs-N1 |
2.332400E-02 |
| N0-vs-N2 |
7.709600E-02 |
| N1-vs-N2 |
6.439400E-01 |
|
|
